Neurosense Therapeutics shares owned by Yorkville Advisors Global
Quarter-by-quarter ownership of Neurosense Therapeutics (NRSN) shares owned by Yorkville Advisors Global
from 13F filings
Historical chart of Yorkville Advisors Global investment in Neurosense Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Neurosense Therapeutics held by Yorkville Advisors Global consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurosense Therapeutics by Yorkville Advisors Global
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $77k | 100k | 0.77 |
| 2025-06-30 | $113k | 60k | 1.89 |